Wolfe Research initiated coverage of Zimmer Biomet with a Peer Perform rating and no price target. The firm sees a $115-$130 fair value range.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ZBH:
- Zimmer Biomet guidance update an ‘unwelcome negative,’ says Truist
- Zimmer news to erase some of recent rally, says Citi
- Zimmer Biomet’s ERP issue likely to pressure sales, EPS estimates, says Stifel
- Zimmer Biomet sees ERP implementation impacting FY24 sales by about 1%
- Unusually active option classes on open September 5th